Survey: medtech start-ups lament lack of VC funding
This article was originally published in Clinica
Executive Summary
Dwindling venture capital funding is the biggest issue facing medical device companies currently, but reimbursement and tightening regulations are also a concern. The latter is particularly timely as firms process the impact of the recently-proposed new EU directives, which are expected to lead to stricter regulations in Europe (www.clinica.co.uk, 26 September 2012).